The Food and Drug Administration recently approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. The ...
CHICAGO (Reuters) - Eli Lilly and Co said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions ...
The U.S. Food and Drug Administration has approved Cymbalta for chronic back pain and osteoarthritis pain, according to a FDA news release. Cymbalta, which was first used to treat major depressive ...
Nerve pain affects millions of people worldwide, creating a burning, shooting, or electric sensation that can make daily activities nearly impossible. Unlike regular pain that responds well to common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results